Premium
Miller‐Fisher syndrome after SARS‐CoV‐2 infection
Author(s) -
ReyesBueno J. A.,
GarcíaTrujillo L.,
Urbaneja P.,
CianoPetersen N. L.,
PostigoPozo M. J.,
MartínezTomás C.,
SerranoCastro P. J.
Publication year - 2020
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/ene.14383
Subject(s) - medicine , covid-19 , pandemic , miller fisher syndrome , encephalopathy , encephalitis , complication , pediatrics , disease , guillain barre syndrome , immunology , infectious disease (medical specialty) , pathology , virus , outbreak
On March 11th, 2020, the WHO declared the SARS‐Cov‐2 pandemic. Syndromes have been detected in relation to COVID‐19 such as encephalitis, acute necrotizing hemorrhagic encephalopathy and cerebrovascular complications. There are also cases of peripheral nervous system involvement. Methods Our case would be the 3rd patient with MFS associated with COVID‐19 as far as we know. Results We present a 51 years old female diagnosed with MFS two weeks after COVID‐19. RTPCR to SARS‐CoV‐2 was negative but IgG was positive. Conclusion Most of the cases were mild or moderate with typical signs and symptoms. All were treated with IV immunoglobulin with good response in most cases. Despite the short evolution time of the cases surviving the current pandemic, the description of cases of post‐infectious neurological syndromes suggests that this is probably not an infrequent complication in the subacute stage of Covid‐19 disease.